Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis

Biological Trace Element Research

Volumn 151, Issue 2, 2013, Pages 159-170

  Roos, Per M ^a,c   Vesterberg, Olof ^b   Syversen, Tore ^d   Flaten, Trond Peder ^d   Nordberg, Monica ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

ALS; Cerebrospinal fluid; HR ICP MS; Metals; Plasma; QEMG

Indexed keywords

ALUMINUM; CADMIUM; COBALT; COPPER; LEAD; MANGANESE; TRACE METAL; URANIUM; VANADIUM; ZINC; BIOLOGICAL MARKER; METAL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOACCUMULATION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROMYOGRAPHY; FEMALE; HUMAN; LIMIT OF DETECTION; MALE; MASS SPECTROMETRY; NEUROPATHOLOGY; NEUROTOXICITY; PLASMA; TRACE METAL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CEREBROSPINAL FLUID; MIDDLE AGED; NORWAY; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL; URINE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; CASE-CONTROL STUDIES; COHORT STUDIES; ELECTROMYOGRAPHY; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; MASS SPECTROMETRY; METALS; MIDDLE AGED; NORWAY;

MLCS; MLOWN;

EID: 84879945341     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-012-9547-x     Document Type: Article

References (61)

1. Charcot J-M (1874) Amyotrophies spinales deuteropatiques sclérose latérale amyotrophique & Sclérose latérale amyotrophique. Bueaux du Progrès Médical 2:234-266
2. Daube JR (2000) Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders. Muscle Nerve 23(10):1488-1502
3. Roos PM, Vesterberg O, Nordberg M (2006) Metals in motor neuron diseases. Exp Biol Med (Maywood) 231(9):1481-1487
4. Conradi S, Ronnevi LO, Nise G, Vesterberg O (1980) Abnormal distribution of lead in amyotrophic lateral sclerosis - reestimation of lead in the cerebrospinal fluid. J Neurol Sci 48(3):413-418
5. Kamel F, Umbach DM, Hu H, Munsat TL, Shefner JM, Taylor JA, Sandler DP (2005) Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis 2(3-4):195-201
6. Yase Y (1972) The pathogenesis of amyotrophic lateral sclerosis. Lancet 2(7772):292-296
7. Gellein K, Garruto RM, Syversen T, Sjobakk TE, Flaten TP (2003) Concentrations of Cd, Co, Cu, Fe, Mn, Rb, V, and Zn in formalin-fixed brain tissue in amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam determined by high-resolution ICP-MS. Biol Trace Elem Res 96(1-3):39-60
8. Garruto RM, Yanagihara R (2009) Contributions of isolated Pacific populations to understanding neurodegenerative diseases. Folia Neuropathol 47(2):149-170
9. Lilienfeld DE, Perl DP (1993) Projected neurodegenerative disease mortality in the United States, 1990-2040. Neuroepidemiology 12(4):219-228
10. Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Sparen P, Fall K, Ye W (2009) Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol 66(4):515-519
11. Maurer MH (2008) Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Mass Spectrom Rev 29(1):17-28
12. Miller RG, Munsat TL, Swash M, Brooks BR (1999) Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology Committee on Research. J Neurol Sci 169(1-2):2-12
13. Higashihara M, Sonoo M (2007) Electrodiagnosis of ALS. Brain Nerve 59(10):1031-1041
14. Gellein K, Roos PM, Evje L, Vesterberg O, Flaten TP, Nordberg M, Syversen T (2007) Separation of proteins including metallothionein in cerebrospinal fluid by size exclusion HPLC and determination of trace elements by HR-ICP-MS. Brain Res 1174:136-142
15. Roos PM, Lierhagen S, Flaten TP, Syversen T, Vesterberg O, Nordberg M (2012) Manganese in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Exp Biol Med (Maywood) 237(7):803-810
16. Rodushkin I, Engstrom E, Stenberg A, Baxter DC (2004) Determination of low-abundance elements at ultra-trace levels in urine and serum by inductively coupled plasma-sector field mass spectrometry. Anal Bioanal Chem 380(2):247-257
17. Agresti A, Min Y (2001) On small-sample confidence intervals for parameters in discrete distributions. Biometrics 57(3):963-971
18. Cytel C (2004) Statistical Software for Exact Nonparametric Inference. Users manual. Stat Xact version 7. Cytel studio, Cambridge
19. Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, Kacew S, Lindsay J, Mahfouz AM, Rondeau V (2007) Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev 10(Suppl 1):1-269
20. Milatovic D, Zaja-Milatovic S, Gupta RC, Yu Y, Aschner M (2009) Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol 240(2):219-225
21. Monnet-Tschudi F, Zurich MG, Boschat C, Corbaz A, Honegger P (2006) Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev Environ Health 21(2):105-117
22. Sanders T, Liu Y, Buchner V, Tchounwou PB (2009) Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health 24(1):15-45
23. Vahidnia A, van der Voet GB, de Wolff FA (2007) Arsenic neurotoxicity - a review. Hum Exp Toxicol 26(10):823-832
24. Michalke B, Halbach S, Nischwitz V (2009) JEM spotlight: metal speciation related to neurotoxicity in humans. J Environ Monit 11(5):939-954
25. Aschner M, Jiang GC (2009) Toxicity studies on depleted uranium in primary rat cortical neurons and in Caenorhabditis elegans: what have we learned? J Toxicol Environ Health B Crit Rev 12(7):525-539
26. Jiang GC, Hughes S, Sturzenbaum SR, Evje L, Syversen T, Aschner M (2009) Caenorhabditis elegans metallothioneins protect against toxicity induced by depleted uranium. Toxicol Sci 111(2):345-354
27. Jiang GC, Tidwell K, McLaughlin BA, Cai J, Gupta RC, Milatovic D, Nass R, Aschner M (2007) Neurotoxic potential of depleted uranium effects in primary cortical neuron cultures and in Caenorhabditis elegans. Toxicol Sci 99(2):553-565
28. Bak TH (2010) Motor neuron disease and frontotemporal dementia: one, two, or three diseases? Ann Indian Acad Neurol 13(Suppl 2):S81-S88
29. Zheng W, Aschner M, Ghersi-Egea JF (2003) Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol 192(1):1-11
30. Schmitt C, Strazielle N, Richaud P, Bouron A, Ghersi-Egea JF (2011) Active transport at the blood-CSF barrier contributes to manganese influx into the brain. J Neurochem 117(4):747-756
31. Roos PM, Dencker L (2012) Mercury in the spinal cord after inhalation of mercury. Basic Clin Pharmacol Toxicol. doi: 0.1111/j.1742-7843.2012.00872.x
32. Flaten TP, Alfrey AC, Birchall JD, Savory J, Yokel RA (1996) Status and future concerns of clinical and environmental aluminum toxicology. J Toxicol Environ Health 48(6):527-541
33. Crapper DR, Krishnan SS, Dalton AJ (1973) Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180(85):511-513
34. Shaw CA, Petrik MS (2009) Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem 103(11):1555-1562
35. Tanridag T, Coskun T, Hurdag C, Arbak S, Aktan S, Yegen B (1999) Motor neuron degeneration due to aluminium deposition in the spinal cord: a light microscopical study. Acta Histochem 101(2):193-201
36. WHO (2001) Vanadium pentioxide and other inorganic vanadium compounds. Document 29. In: Concise international chemical assessment documents. WHO, Geneva
37. Afeseh Ngwa H, Kanthasamy A, Anantharam V, Song C, Witte T, Houk R, Kanthasamy AG (2009) Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease. Toxicol Appl Pharmacol 240(2):273-285
38. Dobson AW, Erikson KM, Aschner M (2004) Manganese neurotoxicity. Ann N Y Acad Sci 1012:115-128
39. Aschner M, Erikson KM, Herrero Hernandez E, Tjalkens R (2009) Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromolecular Med 11(4):252-266
40. Kalia K, Jiang W, Zheng W (2008) Manganese accumulates primarily in nuclei of cultured brain cells. Neurotoxicology 29(3):466-470
41. Miyata S, Nakamura S, Nagata H, Kameyama M (1983) Increased manganese level in spinal cords of amyotrophic lateral sclerosis determined by radiochemical neutron activation analysis. J Neurol Sci 61(2):283-293
42. Xu R, Wu C, Zhang X, Zhang Q, Yang Y, Yi J, Yang R, Tao Y (2011) Linking hypoxic and oxidative insults to cell death mechanisms in models of ALS. Brain Res 1372:133-144
43. Brewer GJ (2010) Risks of copper and iron toxicity during aging in humans. Chem Res Toxicol 23(2):319-326
44. Ibrahimagic OC, Sinanovic O, Zonic L, Hudic J (2006) Amyotrophic lateral sclerosis in younger age associated with abnormality of copper level. Med Arh 60(2):108-109
45. Smith AP, Lee NM (2007) Role of zinc in ALS. Amyotroph Lateral Scler 8(3):131-143
46. Nordberg G, Jin T, Bernard A, Fierens S, Buchet JP, Ye T, Kong Q, Wang H (2002) Low bone density and renal dysfunction following environmental cadmium exposure in China. Ambio 31(6):478-481
47. Nordberg M, Jin T, Nordberg GF (1992) Cadmium, metallothionein and renal tubular toxicity. IARC Sci Publ 118:293-297
48. Basun H, Lind B, Nordberg M, Nordstrom M, Bjorksten KS, Winblad B (1994) Cadmium in blood in Alzheimer's disease and non-demented subjects: results from a population-based study. Biometals 7(2):130-134
49. Bar-Sela S, Reingold S, Richter ED (2001) Amyotrophic lateral sclerosis in a battery-factory worker exposed to cadmium. Int J Occup Environ Health 7(2):109-112
50. Mazliah J, Barron S, Bental E, Rogowski Z, Coleman R, Silbermann M (1989) The effects of long-term lead intoxication on the nervous system of the chicken. Neurosci Lett 101(3):253-257
51. Tanquerel des Planches L (1839) Traité des maladies de plomb ou saturnines. Ferra, Paris
52. Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, Watson M, Keller J, Oddone EZ, Sandler DP, Schmidt S, Kamel F (2010) Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol 171(10):1126-1133
53. Kamel F, Umbach DM, Stallone L, Richards M, Hu H, Sandler DP (2008) Association of lead exposure with survival in amyotrophic lateral sclerosis. Environ Health Perspect 116(7):943-947
54. Barbeito AG, Martinez-Palma L, Vargas MR, Pehar M, Manay N, Beckman JS, Barbeito L, Cassina P (2011) Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS. Neurobiol Dis 37(3):574-580
55. Oh SS, Kim EA, Lee SW, Kim MK, Kang SK (2007) A case of amyotrophic lateral sclerosis in electronic parts manufacturing worker exposed to lead. Neurotoxicology 28(2):324-327
56. Nordberg G, Fowler B, Nordberg M, Friberg LT (eds) (2007) Handbook on the toxicology of metals, 3rd edn. Elsevier, New York
57. Morris KJ, Townsend KM, Batchelor AL (1989) Studies of alveolar cell morphometry and mass clearance in the rat lung following inhalation of an enriched uranium dioxide aerosol. Radiat Environ Biophys 28(2):141-154
58. Houpert P, Frelon S, Monleau M, Bussy C, Chazel V, Paquet F (2007) Heterogeneous accumulation of uranium in the brain of rats. Radiat Prot Dosimetry 127(1-4):86-89
59. WHO (2004) WHO health criteria for uranium on-line (2003). WHO guidelines for drinking water quality, 3rd edn. WHO, Geneva
60. Ishaque AB, Johnson L, Gerald T, Boucaud D, Okoh J, Tchounwou PB (2006) Assessment of individual and combined toxicities of four non-essential metals (As, Cd, Hg and Pb) in the microtox assay. Int J Environ Res Public Health 3(1):118-120
61. Rai A, Maurya SK, Khare P, Srivastava A, Bandyopadhyay S (2011) Characterization of developmental neurotoxicity of As, Cd, and Pb mixture: synergistic action of metal mixture in glial and neuronal functions. Toxicol Sci 118(2):586-601